Most recently, it has been determined that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in comparable parts as classical opioid receptors, it binds into a big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts for a scavenger and does not activate